Last reviewed · How we verify
Topiramate; flunarizine
At a glance
| Generic name | Topiramate; flunarizine |
|---|---|
| Sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- ACT Therapy for HF Migraine (NA)
- Chinese Real-world Study of Treatment of Vestibular Migraine
- Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care (PHASE4)
- Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine (NA)
- Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis (PHASE4)
- A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: